Skip to content

Homoeopathic Medicine for Ovarian Cyst

COMPUTATIONAL ELUCIDATION OF PULSATILLA NIGRICANS AS POTENTIAL REGULATOR FOR PCOS AND EXPLORING ITS CLINICAL UTILITY USING A SINGLE ARM TRIAL OF PRE-POST COMPARISON DESIGN - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058231
Enrollment
34
Registered
2023-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Homoeopathic Medicine Pulsatilla Nigricans in Centicimal Potency: Administering Pulsatilla Nigricans homoeopathic medicine for a period of 6 months. Medicine will be dispensed in centic

Sponsors

National Institute of Homoeopathy
Lead Sponsor
NIPER KOLKATA
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed PCOS as per Rotterdam diagnostic criteria. 2.Age 18-45 years. 3.Symptomatic for at least last 3 months. 4.The symptoms indicating Pulsatilla nigricans as a Similimum remedy. 5.Patients taking oral contraceptive pills (OCPs) to be included after a wash out period of 3 months. 6.Patients under hormonal replacement therapy (HRT) to be included after a wash out period of 3 months. 7.Patients with known but controlled systemic diseases with medication. 8.Patients giving written consent to participate.

Exclusion criteria

Exclusion criteria: 1.Unevaluated gynaecological abnormalities; e.g., unexplained vaginal bleeding, cervical dysplasia, pelvic inflammatory diseases (PID) within one month. 2.Genito-urinary tract malignancy 3.Patients desiring immediate surgical management for PCOS 4.Patients insisting to use OCPs 5.Patients with psychiatric diseases 6.Pregnancy and lactation 7.Cases suffering from uncontrolled systemic illness or life-threatening infections or any vital organ failure 8.Cases already undergoing homoeopathic treatment for any chronic purpose 9.Substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
The assessment of the outcome of the treatment will be done by the changes that occur in the MPCOSQ score. Modified PCOS Questionnaire (MPCOSQ)Timepoint: Baseline and 6 months

Secondary

MeasureTime frame
By USG of Abdomen and Serological StudyTimepoint: Baseline and Last month

Countries

India

Contacts

Public ContactDr Ompriya Mishra

National Institute of Homoeopathy

drompriyanih@gmail.com9432496545

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026